Literature DB >> 29706235

COSCA (Core Outcome Set for Cardiac Arrest) in Adults: An Advisory Statement From the International Liaison Committee on Resuscitation.

Kirstie Haywood, Laura Whitehead, Vinay M Nadkarni, Felix Achana, Stefanie Beesems, Bernd W Böttiger, Anne Brooks, Maaret Castrén, Marcus E H Ong, Mary Fran Hazinski, Rudolph W Koster, Gisela Lilja, John Long, Koenraad G Monsieurs, Peter T Morley, Laurie Morrison, Graham Nichol, Valentino Oriolo, Gustavo Saposnik, Michael Smyth, Ken Spearpoint, Barry Williams, Gavin D Perkins.   

Abstract

Cardiac arrest effectiveness trials have traditionally reported outcomes that focus on survival. A lack of consistency in outcome reporting between trials limits the opportunities to pool results for meta-analysis. The COSCA initiative (Core Outcome Set for Cardiac Arrest), a partnership between patients, their partners, clinicians, research scientists, and the International Liaison Committee on Resuscitation, sought to develop a consensus core outcome set for cardiac arrest for effectiveness trials. Core outcome sets are primarily intended for large, randomised clinical effectiveness trials (sometimes referred to as pragmatic trials or phase III/IV trials) rather than for pilot or efficacy studies. A systematic review of the literature combined with qualitative interviews among cardiac arrest survivors was used to generate a list of potential outcome domains. This list was prioritised through a Delphi process, which involved clinicians, patients, and their relatives/partners. An international advisory panel narrowed these down to 3 core domains by debate that led to consensus. The writing group refined recommendations for when these outcomes should be measured and further characterised relevant measurement tools. Consensus emerged that a core outcome set for reporting on effectiveness studies of cardiac arrest (COSCA) in adults should include survival, neurological function, and health-related quality of life. This should be reported as survival status and modified Rankin scale score at hospital discharge, at 30 days, or both. Health-related quality of life should be measured with ≥1 tools from Health Utilities Index version 3, Short-Form 36-Item Health Survey, and EuroQol 5D-5L at 90 days and at periodic intervals up to 1 year after cardiac arrest, if resources allow. © 2018 European Resuscitation Council and American Heart Association, Inc. Published by Elsevier B.V. All rights reserved.
Copyright © 2018 European Resuscitation Council and American Heart Association, Inc. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AHA Scientific Statements; Cardiac arrest; Consensus; Quality of life; Treatment outcome

Mesh:

Year:  2018        PMID: 29706235     DOI: 10.1016/j.resuscitation.2018.03.022

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  28 in total

Review 1.  The present and future of cardiac arrest care: international experts reach out to caregivers and healthcare authorities.

Authors:  Jerry P Nolan; Robert A Berg; Clifton W Callaway; Laurie J Morrison; Vinay Nadkarni; Gavin D Perkins; Claudio Sandroni; Markus B Skrifvars; Jasmeet Soar; Kjetil Sunde; Alain Cariou
Journal:  Intensive Care Med       Date:  2018-06-02       Impact factor: 17.440

2.  [Adrenaline in patients with out-of-hospital cardiac arrest : PARAMEDIC2 trial].

Authors:  U Janssens; G Michels
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-08-28       Impact factor: 0.840

Review 3.  Core outcomes sets for studies evaluating critical illness and patient recovery.

Authors:  Victor D Dinglas; Sai P S Cherukuri; Dale M Needham
Journal:  Curr Opin Crit Care       Date:  2020-10       Impact factor: 3.687

4.  European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care.

Authors:  Jerry P Nolan; Claudio Sandroni; Bernd W Böttiger; Alain Cariou; Tobias Cronberg; Hans Friberg; Cornelia Genbrugge; Kirstie Haywood; Gisela Lilja; Véronique R M Moulaert; Nikolaos Nikolaou; Theresa Mariero Olasveengen; Markus B Skrifvars; Fabio Taccone; Jasmeet Soar
Journal:  Intensive Care Med       Date:  2021-03-25       Impact factor: 17.440

Review 5.  Advanced Life Support Update.

Authors:  Gavin D Perkins; Jerry P Nolan
Journal:  Crit Care       Date:  2022-03-22       Impact factor: 9.097

6.  Adrenaline and vasopressin for cardiac arrest.

Authors:  Judith Finn; Ian Jacobs; Teresa A Williams; Simon Gates; Gavin D Perkins
Journal:  Cochrane Database Syst Rev       Date:  2019-01-17

7.  Development of a core outcome set for pediatric critical care outcomes research.

Authors:  Ericka L Fink; Jessica M Jarvis; Aline B Maddux; Neethi Pinto; Patrick Galyean; Lenora M Olson; Susan Zickmund; Melissa Ringwood; Samuel Sorenson; J Michael Dean; Joseph A Carcillo; Robert A Berg; Athena Zuppa; Murray M Pollack; Kathleen L Meert; Mark W Hall; Anil Sapru; Patrick S McQuillen; Peter M Mourani; R Scott Watson
Journal:  Contemp Clin Trials       Date:  2020-03-05       Impact factor: 2.226

Review 8.  [Ethics of resuscitation and end of life decisions].

Authors:  Spyros D Mentzelopoulos; Keith Couper; Patrick Van de Voorde; Patrick Druwé; Marieke Blom; Gavin D Perkins; Ileana Lulic; Jana Djakow; Violetta Raffay; Gisela Lilja; Leo Bossaert
Journal:  Notf Rett Med       Date:  2021-06-02       Impact factor: 0.826

Review 9.  Anticipatory manual defibrillator charging during advanced life support: A scoping review.

Authors:  Quentin Otto; Szymon Musiol; Charles D Deakin; Peter Morley; Jasmeet Soar
Journal:  Resusc Plus       Date:  2020-05-21

10.  Vasopressin and methylprednisolone for in-hospital cardiac arrest - Protocol for a randomized, double-blind, placebo-controlled trial.

Authors:  Lars W Andersen; Birthe Sindberg; Mathias Holmberg; Dan Isbye; Jesper Kjærgaard; Stine T Zwisler; Søren Darling; Jacob Moesgaard Larsen; Bodil S Rasmussen; Bo Løfgren; Kasper Glerup Lauridsen; Kim B Pælestik; Christoffer Sølling; Anders G Kjærgaard; Dorte Due-Rasmussen; Fredrik Folke; Mette Gitz Charlot; Kasper Iversen; Martin Schultz; Sebastian Wiberg; Rikke Malene H G Jepsen; Tobias Kurth; Michael Donnino; Hans Kirkegaard; Asger Granfeldt
Journal:  Resusc Plus       Date:  2021-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.